(Q35016972)

5 August 2017

1 reference

title

Voriconazole: in the treatment of invasive aspergillosis (English)

1 reference

5 August 2017

0 references

1 reference

3

Lesley J Scott

1 reference

5 August 2017

Richard B R Muijsers

1

1 reference

PubMed ID

12466006

5 August 2017

Karen L Goa

series ordinal

2

1 reference

5 August 2017

1 January 2002

1 reference

5 August 2017

1 reference

5 August 2017

62

1 reference

5 August 2017

18

1 reference

5 August 2017

2655-64; discussion 2665-6

1 reference

https://scigraph.springernature.com/pub.10.2165/00003495-200262180-00010

5 August 2017

0 references

cites work

Current and emerging azole antifungal agents

1 reference

12 December 2020

Comparison of the in-vitro activity of voriconazole (UK-109,496), itraconazole and amphotericin B against clinical isolates of Aspergillus fumigatus

1 reference

12 December 2020

In vitro amphotericin B resistance in clinical isolates of Aspergillus terreus, with a head-to-head comparison to voriconazole.

1 reference

12 December 2020

Evaluation of possible correlations between antifungal susceptibilities of filamentous fungi in vitro and antifungal treatment outcomes in animal infection models

1 reference

12 December 2020

A new triazole, voriconazole (UK-109,496), blocks sterol biosynthesis in Candida albicans and Candida krusei

1 reference

12 December 2020

Successful treatment of cerebral aspergillosis with a novel triazole (voriconazole) in a patient with acute leukaemia.

1 reference

12 December 2020

Germinated and nongerminated conidial suspensions for testing of susceptibilities of Aspergillus spp. to amphotericin B, itraconazole, posaconazole, ravuconazole, and voriconazole

1 reference

12 December 2020

Antigen detection in the diagnosis and management of a patient with probable cerebral aspergillosis treated with voriconazole

1 reference

12 December 2020

New drugs and novel targets for treatment of invasive fungal infections in patients with cancer

1 reference

12 December 2020

Comparison of voriconazole (UK-109,496) and itraconazole in prevention and treatment of Aspergillus fumigatus endocarditis in guinea pigs

1 reference

12 December 2020

Efficacy of voriconazole in a guinea pig model of disseminated invasive aspergillosis

1 reference

12 December 2020

Voriconazole in the treatment of aspergillosis, scedosporiosis and other invasive fungal infections in children

1 reference

12 December 2020

Quantitation of Candida albicans ergosterol content improves the correlation between in vitro antifungal susceptibility test results and in vivo outcome after fluconazole treatment in a murine model of invasive candidiasis

1 reference

12 December 2020

Pharmacokinetics and safety of voriconazole following intravenous- to oral-dose escalation regimens

1 reference

12 December 2020

Muco-cutaneous retinoid-effects and facial erythema related to the novel triazole antifungal agent voriconazole.

1 reference

12 December 2020

Antifungal activities of posaconazole, ravuconazole, and voriconazole compared to those of itraconazole and amphotericin B against 239 clinical isolates of Aspergillus spp. and other filamentous fungi: report from SENTRY Antimicrobial Surveillance P

1 reference

12 December 2020

In vitro efficacy and fungicidal activity of voriconazole against Aspergillus and Fusarium species

1 reference

12 December 2020

Antifungal activity of a new triazole, voriconazole (UK-109496), against clinical isolates of Aspergillus spp.

1 reference

12 December 2020

Successful treatment of invasive aspergillosis in chronic granulomatous disease by granulocyte transfusions followed by peripheral blood stem cell transplantation

1 reference

12 December 2020

In vitro susceptibilities of Aspergillus species to voriconazole, itraconazole, and amphotericin B.

1 reference

12 December 2020

Activity of voriconazole (UK-109,496) against clinical isolates of Aspergillus species and its effectiveness in an experimental model of invasive pulmonary aspergillosis

1 reference

12 December 2020

Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis

1 reference

12 December 2020

Successful treatment with voriconazole of invasive aspergillosis in chronic granulomatous disease

1 reference

12 December 2020

Efficacy and safety of voriconazole in the treatment of acute invasive aspergillosis

1 reference

12 December 2020

Antifungal drug susceptibility testing and resistance in Aspergillus

1 reference

12 December 2020

Efficacy of UK-109496, a new azole antifungal agent, in an experimental model of invasive aspergillosis.

1 reference

12 December 2020

Microgranulomatous aspergillosis in a patient with chronic granulomatous disease: cure with voriconazole

1 reference

12 December 2020

In-vitro activity of voriconazole against Aspergillus spp. and comparison with itraconazole and amphotericin B.

1 reference

12 December 2020

10.2165/00003495-200262180-00010

Identifiers

DOI

1 reference

PubMed ID

12466006

Dimensions Publication ID

5 August 2017

0 references

1 reference

PubMed ID

12466006